Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Autolus Therapeutics (AUTL) over the last 5 years, with Q3 2025 value amounting to 0.91%.

  • Autolus Therapeutics' Return on Invested Capital fell 4800.0% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.9% for FY2024, which is 300.0% down from last year.
  • Autolus Therapeutics' Return on Invested Capital amounted to 0.91% in Q3 2025, which was down 4800.0% from 0.77% recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Return on Invested Capital high stood at 0.35% for Q2 2024, and its period low was 1.23% during Q4 2023.
  • Moreover, its 4-year median value for Return on Invested Capital was 0.61% (2023), whereas its average is 0.63%.
  • In the last 5 years, Autolus Therapeutics' Return on Invested Capital plummeted by -6100bps in 2023 and then surged by 6900bps in 2024.
  • Over the past 4 years, Autolus Therapeutics' Return on Invested Capital (Quarter) stood at 0.62% in 2022, then plummeted by -98bps to 1.23% in 2023, then surged by 56bps to 0.54% in 2024, then crashed by -70bps to 0.91% in 2025.
  • Its Return on Invested Capital was 0.91% in Q3 2025, compared to 0.77% in Q2 2025 and 0.68% in Q1 2025.